Nervgen Pharma NGEN
NASDAQ NGEN
$1.86 +0.10 (+5.68%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Selling, General & Administrative (2025 - 2026)

Nervgen Pharma (NGEN) Selling, General & Administrative (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.13 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 216.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 593.21 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 347.92 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -196.26 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 247.47 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 161.89 Mn
10 Nervgen Pharma 168.94 Mn 168.94 Mn - 3.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.95 Mn
Mar 31, 2025 2.01 Mn